Landiao, Cherilyn S.

HRN: 17-58-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/04/2024
03/10/2024
IVTT
500 Mg
Q8
Amoebic Dysentery
Waiting Final Action 
03/05/2024
METRONIDAZOLE 500MG (TAB)
03/05/2024
03/11/2024
ORAL
500mg
TID
T/C Amoebic Dysentery
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: